
|Videos|December 9, 2020
Dr. Katie Murray on the challenges of treating low-grade UTUC
Author(s)Urology Times staff
Murray also discusses the low-grade upper tract urothelial cancer treatment mitomycin-containing reverse thermal gel (Jelmyto).
Advertisement
In this video, Katie Murray, DO, explains what makes low-grade upper tract urothelial cancer difficult to treat and also discusses mitomycin-containing reverse thermal gel (Jelmyto). Murray is an assistant professor of surgery-urology at the University of Missouri, Columbia.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Taylor Goodstein, MD, highlights contemporary experience with gene therapies for NMIBC
3
Real-World Evidence in mCSPC Management
4
Jim Hu, MD, discusses new posterior approach to nerve-sparing prostatectomy
5



















